Eligibility Advanced or Metastatic Breast Cancer, NCT01625286

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
female patient
Beschreibung

female patient

Datentyp

boolean

Alias
UMLS CUI [1]
C0150905
aged at least 18 years
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
histological or cytological confirmation of breast cancer with evidence of advanced or metastatic disease (must be er+ve, her2-ve, in part b).
Beschreibung

breast cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
world health organisation (who) performance status 0-1 with no deterioration over the previous 2 weeks and minimum life expectancy of 12 weeks.
Beschreibung

who performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1298650
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinically significant abnormalities of glucose metabolism
Beschreibung

clinically significant abnormalities of glucose metabolism

Datentyp

boolean

Alias
UMLS CUI [1]
C0744434
spinal cord compression or brain metastases unless asymptomatic, treated and stable (not requiring steroids).
Beschreibung

spinal cord compression

Datentyp

boolean

Alias
UMLS CUI [1]
C0037926
UMLS CUI [2]
C0220650
evidence of severe or uncontrolled systemic diseases, including active bleeding diatheses or active infections including hepatitis b, c and hiv.
Beschreibung

systemic diseases, bleeding diatheses

Datentyp

boolean

Alias
UMLS CUI [1]
C1536063
UMLS CUI [2]
C0442893
any prior exposure to agents which inhibit akt as the primary pharmacological activity.
Beschreibung

inhibit akt

Datentyp

boolean

Alias
UMLS CUI [1]
C0812228
part a: more than two prior courses of chemotherapy (including taxanes) for advanced or metastatic breast cancer.
Beschreibung

chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
part b: any prior chemotherapy for advanced or metastatic breast cancer.
Beschreibung

chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0278488

Ähnliche Modelle

Eligibility Advanced or Metastatic Breast Cancer, NCT01625286

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
female patient
Item
female patient
boolean
C0150905 (UMLS CUI [1])
age
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
histological or cytological confirmation of breast cancer with evidence of advanced or metastatic disease (must be er+ve, her2-ve, in part b).
boolean
C0678222 (UMLS CUI [1])
who performance status
Item
world health organisation (who) performance status 0-1 with no deterioration over the previous 2 weeks and minimum life expectancy of 12 weeks.
boolean
C1298650 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
clinically significant abnormalities of glucose metabolism
Item
clinically significant abnormalities of glucose metabolism
boolean
C0744434 (UMLS CUI [1])
spinal cord compression
Item
spinal cord compression or brain metastases unless asymptomatic, treated and stable (not requiring steroids).
boolean
C0037926 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
systemic diseases, bleeding diatheses
Item
evidence of severe or uncontrolled systemic diseases, including active bleeding diatheses or active infections including hepatitis b, c and hiv.
boolean
C1536063 (UMLS CUI [1])
C0442893 (UMLS CUI [2])
inhibit akt
Item
any prior exposure to agents which inhibit akt as the primary pharmacological activity.
boolean
C0812228 (UMLS CUI [1])
chemotherapy
Item
part a: more than two prior courses of chemotherapy (including taxanes) for advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1])
chemotherapy
Item
part b: any prior chemotherapy for advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])